Mark C Burgmans, MD PhD — Biomedical Watch V2

Traitements2programmes

Essais1liés

Publications0liées

SourceDBlocale

Traitements

2

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
PreciseOnco — Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image GuidanceThis study collects data from patients undergoing minimally invasive, image-guided cancer treatments at participating hospitals in the Netherlands and France. All treatments are performed as standard clinical care and include procedures such as tumor ablation and catheter-based treatments of cancer in the liver, kidney, lung, and bone. During these procedures, a spectral angio-CT system is used for image guidance. This advanced CT scanner automatically captures additional imaging information beyond what is used in routine clinical decision-making. The goal of this study is to investigate how this additional imaging information is associated with treatment outcomes, and how it can be used in the future to improve treatment planning, procedural guidance, and prediction of treatment results. No experimental interventions are performed. Participation does not alter the treatment or follow-up patients receive. Data are collected from medical records and imaging systems and stored securely for analysis.	Cancer	À vérifier	À vérifier	France, Netherlands	À vérifier
PreciseOnco — Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image GuidanceThis study collects data from patients undergoing minimally invasive, image-guided cancer treatments at participating hospitals in the Netherlands and France. All treatments are performed as standard clinical care and include procedures such as tumor ablation and catheter-based treatments of cancer in the liver, kidney, lung, and bone. During these procedures, a spectral angio-CT system is used for image guidance. This advanced CT scanner automatically captures additional imaging information beyond what is used in routine clinical decision-making. The goal of this study is to investigate how this additional imaging information is associated with treatment outcomes, and how it can be used in the future to improve treatment planning, procedural guidance, and prediction of treatment results. No experimental interventions are performed. Participation does not alter the treatment or follow-up patients receive. Data are collected from medical records and imaging systems and stored securely for analysis.	Cancer	À vérifier	À vérifier	France, Netherlands	À vérifier

Essais cliniques

1

Molécule	Indication / population	Phase	NCT	Titre	Statut
PreciseOnco — Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance	Cancer	À vérifier	NCT07636148	PreciseOnco — Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance	RECRUITING

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.